微创’s cardiac rhythm management subsidiary — MicroPort CRM — announced in May that itreceived FDA approval for its Alizea and Celea implantable pacemakers. Microport said its newly approved devices are the longest-lasting pacemakers for their size on the market today. They offer a volume of just 11 cc and a projected longevity of 13 years.–CN